Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Lutonix

Request full access

New drug-coated balloon catheter that delivers paclitaxel to the arterial wall in a single, short inflation

Maple Grove, United StatesFounded 2007Health Tech & Medtech

About Lutonix

Lutonix specializes in the development and commercialization of drug-coated balloons (DCBs) for angioplasty procedures. The company operates in the medical device market, primarily serving healthcare providers and medical institutions that perform vascular interventions. Lutonix's core product, the Lutonix DCB, is the first and only DCB to receive FDA approval for use in long lesions up to 300mm and dysfunctional arteriovenous (AV) fistulae. This product is designed to improve patient outcomes by reducing the need for repeat interventions compared to standard angioplasty.

Lutonix generates revenue through the sale of its DCBs, which are available in various sizes and configurations to meet the needs of different vascular conditions. The company also participates in clinical trials and maintains a global registry to provide evidence of the efficacy and safety of its products. By focusing on innovation and regulatory compliance, Lutonix aims to maintain its leadership position in the DCB market.

Source: Dealroom company data

At a glance

Status
Acquired
Employees
10
Open positions
None listed
Dealroom signal
59.1/100
Industry
Health
Sub-industry
Medical Devices
Sector
Surgery, Cardiology and cardiovascular, Catheters, Hard Tech, DT and LS, science-based
Technology
Deep Tech
Business model
Manufacturing
Client focus
B2B

Funding history

4 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
ACQUISITION✓Exit Dec 2011 $225M $225M C. R. Bard —
SERIES C✓Equity / VC Dec 2010 $10M $40M Undisclosed —
Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

Lutonix website traffic

Latest recorded traffic for Lutonix is 0 monthly website visits. Lutonix's team grew 0% over the past year.

Latest monthly visits0 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Lutonix in the Maple Grove ecosystem

Live from Dealroom

The Lutonix office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

4 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

Other known investors3 additional known investors

  • C. R. Bard
  • RiverVest Venture Partners
  • Vensana Capital
Team profiled 4 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · Maple Grove HQ
Book a demo for the full country breakdown

See Lutonix’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.